Carolinas HealthCare System

Research and Clinical Trials

Title  
INTRADETRUSOR
Brief Description  
A Phase III, Multicenter, Randomised, Double-Blind, Parallel Group, Placebo Controlled Study to Assess the Efficacy and Safety of one or more Intradetrusor Treatments of 600 or 800 Units of Dysport for the Treatment of Urinary Incontinence in Subjects With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury or Multiple Sclerosis
Who may be Eligible  
Male or female, aged 18 to 80 years inclusive with UI for at least 3 months prior to screening as a result of NDQ due to SCI or MS.
Start Date  
08/01/2016
IRB Number  
08-16-10B
Principal Investigator  
Kennelly, Michael
Contact Name  
Ali

For More Information, Contact   Ali  DeMarco , BS
Phone:  (704) 355-1970  Fax:  (704) 355-0000 
Email:  Ali.Demarco@carolinashealthcare.org
Address:  1023 Edgehill Road
Charlotte, NC 28207
Close